Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Biodegradable Nanovectors As a Direct Platform for the Controlled Delivery of Chemotherapeutic Drugs Against Childhood ALL

Benjamin C Ede, PhD, Paraskevi Diamanti, PhD, David C Williams, PhD, Allison Blair, PhD

Blood (2020) 136 (Supplement 1): 9.

https://doi.org/10.1182/blood-2020-141222

Published: 2020

Journal Articles

Evaluating ROR1 As a Target in Childhood Leukemia

Paraskevi Diamanti, PhD, Bethan Kathleen Bailey, BSc, Obinna Ebere Iheanacho, MD, Amit C. Nathwani, MD PhD, Allison Blair, PhD

Blood (2019) 134 (Supplement_1): 2635.

https://doi.org/10.1182/blood-2019-126734

Published: 2019

Journal Articles

Combining Parthenolide and Sulfasalazine Improves Toxicity to CD200 + LIC Populations in Childhood ALL

Paraskevi Diamanti, PhD, Anas Al-Masri, BPharm, Benjamin C Ede, PhD, Allison Blair, PhD

Blood (2018) 132 (Supplement 1): 4033.

https://doi.org/10.1182/blood-2018-99-115996

Published: 2018

Journal Articles

Investigating the Efficacy of Anti-CD200 Immunotherapy in MRD Low and Risk B Cell Precursor ALL

Paraskevi Diamanti, PhD, Saifurrizal Saifurrizal, MD, Charlotte V. Cox, BSc, Penka S. Petrova, PhD, Robert A. Uger, PhD, Allison Blair, PhD

Blood (2017) 130 (Supplement 1): 3886.

https://doi.org/10.1182/blood.V130.Suppl_1.3886.3886

Published: 2017

Journal Articles

Investigating the Effects of Anti-CD200 Therapy for Childhood ALL

Paraskevi Diamanti, BSc, PhD, Charlotte V. Cox, BSc, Benjamin C Ede, BSc, Penka S. Petrova, PhD, Robert A. Uger, PhD, Allison Blair, PhD BSc

Blood (2016) 128 (22): 4021.

https://doi.org/10.1182/blood.V128.22.4021.4021

Published: 2016

Journal Articles

A Novel Combination Therapy for Paediatric T Cell Acute Lymphoblastic Leukaemia

Ben Christopher Ede, Bsc, Paraskevi Diamanti, BSc, PhD, Charlotte V. Cox, BSc, Allison Blair, PhD BSc

Blood (2015) 126 (23): 3767.

https://doi.org/10.1182/blood.V126.23.3767.3767

Published: 2015

Journal Articles

Combining BCL-2 Inhibitors with Parthenolide to Treat Childhood Acute Lymphoblastic Leukaemia

Paraskevi Diamanti, BSc, PhD, William J Barendt, BSc, Benjamin C Ede, BSc, Charlotte V. Cox, BSc, Allison Blair, PhD BSc

Blood (2015) 126 (23): 2531.

https://doi.org/10.1182/blood.V126.23.2531.2531

Published: 2015

Journal Articles

CD200 May be a Potential Target for Therapy in Standard Risk Childhood ALL

Charlotte Victoria Cox, BSc, Paraskevi Diamanti, BSc, PhD, Matthew Hazell, BSc, PhD, Allison Blair, PhD BSc

Blood (2014) 124 (21): 4787.

https://doi.org/10.1182/blood.V124.21.4787.4787

Published: 2014

Journal Articles

Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia

Mark T. S. Williams, Yasar Yousafzai, Charlotte Cox, Allison Blair, Ruaidhrí Carmody, Shuji Sai, Karen E. Chapman, Rachel McAndrew, Angela Thomas, Alison Spence, Brenda Gibson, Gerard J. Graham, Christina Halsey

Blood (2014) 123 (20): 3116–3127.

https://doi.org/10.1182/blood-2013-05-499970

Published: 2014

Includes: Supplemental data

Journal Articles

Do Proteasome and Heat Shock Protein Inhibitors Eliminate Leukaemia Initiating Cell Populations In Childhood ALL?

Paraskevi Diamanti, BSc, PhD, Charlotte Victoria Cox, BSc, Allison Blair, PhD, BSc

Blood (2013) 122 (21): 3912.

https://doi.org/10.1182/blood.V122.21.3912.3912

Published: 2013

Journal Articles

Does Expression Of CD200 Provide a Target For LIC In Childhood ALL?

Charlotte Victoria Cox, BSc, Paraskevi Diamanti, BSc, PhD, Allison Blair, PhD, BSc

Blood (2013) 122 (21): 2894.

https://doi.org/10.1182/blood.V122.21.2894.2894

Published: 2013

Journal Articles

Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia

Paraskevi Diamanti, Charlotte V. Cox, John P. Moppett, Allison Blair

Blood (2013) 121 (8): 1384–1393.

https://doi.org/10.1182/blood-2012-08-448852

Published: 2013

Includes: Supplemental data

Journal Articles

Assessing CD97 and CD99 As Markers of Leukaemia Initiating Cells in Paediatric ALL

Charlotte Victoria Cox, BSc, Paraskevi Diamanti, BSc, PhD, Allison Blair, PhD, BSc

Blood (2012) 120 (21): 1882.

https://doi.org/10.1182/blood.V120.21.1882.1882

Published: 2012

Journal Articles

Investigating the Expression of the MRD Marker CD58 on Leukaemia Initiating Cells in Childhood Acute Lymphoblastic Leukaemia

Charlotte Victoria Cox, BSc, Paraskevi Diamanti, BSc, PhD, Allison Blair, PhD, BSc

Blood (2011) 118 (21): 1887.

https://doi.org/10.1182/blood.V118.21.1887.1887

Published: 2011

Journal Articles

Investigating the Effect of Hsp90 Inhibitors on Initiating Cells in Childhood Acute Lymphoblastic Leukaemia

Paraskevi Diamanti, BSc, PhD, Charlotte Victoria Cox, BSc, Allison Blair, PhD, BSc

Blood (2011) 118 (21): 2952.

https://doi.org/10.1182/blood.V118.21.2952.2952

Published: 2011

Journal Articles

Investigating Drug Resistance In Leukemia Initiating Cell Populations.

Paraskevi Diamanti, BSc, PhD, Charlotte Victoria Cox, BSc, Allison Blair, PhD, BSc

Blood (2010) 116 (21): 1570.

https://doi.org/10.1182/blood.V116.21.1570.1570

Published: 2010

Journal Articles

Stem Cells in Paediatric Leukaemia Are Resistant to Parthenolide.

Charlotte Victoria Cox, BSc, Paraskevi Diamanti, BSc, PhD, Allison Blair, PhD

Blood (2009) 114 (22): 1429.

https://doi.org/10.1182/blood.V114.22.1429.1429

Published: 2009

Journal Articles

Stem cells in childhood acute lymphoblastic leukemia: identifying the most relevant targets for therapy

Paraskevi Diamanti, Allison Blair

Blood (2009) 113 (18): 4477.

https://doi.org/10.1182/blood-2009-02-203786

Published: 2009

Journal Articles

Expression of CD133 on leukemia-initiating cells in childhood ALL

Charlotte V. Cox, Paraskevi Diamanti, Roger S. Evely, Pamela R. Kearns, Allison Blair

Blood (2009) 113 (14): 3287–3296.

https://doi.org/10.1182/blood-2008-04-154187

Published: 2009

Includes: Supplemental data

Journal Articles

Growth Factor Deprivation Combined with Prolonged Inhibition of BCR-ABL Does Not Eradicate Functional CML Stem Cells

Ashley Hamilton, Gudmundur V Helgason, Elaine Allan, Michael J. Alcorn, PhD, Franck E Nicolini, MD, PhD, Allison Blair, PhD, BSc, Mirle Schemionek, Steffen Koschmieder, MD, Valerie G Brunton, Tessa L Holyoake

Blood (2008) 112 (11): 4222.

https://doi.org/10.1182/blood.V112.11.4222.4222

Published: 2008

NARROW

Biodegradable Nanovectors As a Direct Platform for the Controlled Delivery of Chemotherapeutic Drugs Against Childhood ALL

Evaluating ROR1 As a Target in Childhood Leukemia

Combining Parthenolide and Sulfasalazine Improves Toxicity to CD200 + LIC Populations in Childhood ALL

Investigating the Efficacy of Anti-CD200 Immunotherapy in MRD Low and Risk B Cell Precursor ALL

Investigating the Effects of Anti-CD200 Therapy for Childhood ALL

A Novel Combination Therapy for Paediatric T Cell Acute Lymphoblastic Leukaemia

Combining BCL-2 Inhibitors with Parthenolide to Treat Childhood Acute Lymphoblastic Leukaemia

CD200 May be a Potential Target for Therapy in Standard Risk Childhood ALL

Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia

Do Proteasome and Heat Shock Protein Inhibitors Eliminate Leukaemia Initiating Cell Populations In Childhood ALL?

Does Expression Of CD200 Provide a Target For LIC In Childhood ALL?

Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia

Assessing CD97 and CD99 As Markers of Leukaemia Initiating Cells in Paediatric ALL

Investigating the Expression of the MRD Marker CD58 on Leukaemia Initiating Cells in Childhood Acute Lymphoblastic Leukaemia

Investigating the Effect of Hsp90 Inhibitors on Initiating Cells in Childhood Acute Lymphoblastic Leukaemia

Investigating Drug Resistance In Leukemia Initiating Cell Populations.

Stem Cells in Paediatric Leukaemia Are Resistant to Parthenolide.

Stem cells in childhood acute lymphoblastic leukemia: identifying the most relevant targets for therapy

Expression of CD133 on leukemia-initiating cells in childhood ALL

Growth Factor Deprivation Combined with Prolonged Inhibition of BCR-ABL Does Not Eradicate Functional CML Stem Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only